Achten, R., van Luijk, C., Thijs, J., Drylewicz, J., Delemarre, E., Nierkens, S., . . . Kuiper, J. (2024). Non-Infectious Uveitis Secondary to Dupilumab Treatment in Atopic Dermatitis Patients Shows a Pro-Inflammatory Molecular Profile. Ocular Immunology & Inflammation, 32(7), 1150. https://doi.org/10.1080/09273948.2023.2182325
Chicago Style (17th ed.) CitationAchten, Roselie, et al. "Non-Infectious Uveitis Secondary to Dupilumab Treatment in Atopic Dermatitis Patients Shows a Pro-Inflammatory Molecular Profile." Ocular Immunology & Inflammation 32, no. 7 (2024): 1150. https://doi.org/10.1080/09273948.2023.2182325.
MLA (9th ed.) CitationAchten, Roselie, et al. "Non-Infectious Uveitis Secondary to Dupilumab Treatment in Atopic Dermatitis Patients Shows a Pro-Inflammatory Molecular Profile." Ocular Immunology & Inflammation, vol. 32, no. 7, 2024, p. 1150, https://doi.org/10.1080/09273948.2023.2182325.